Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Boston Scientific (NY: BSX )

67.44 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 67.44
Bid (Size) 66.72 (1)
Ask (Size) 68.12 (1)
Prev. Close 67.44
Today's Range 67.44 - 67.44
52wk Range 48.35 - 69.21
Shares Outstanding 1,423,852,648
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA
BofA Securities' upgrades Integer, highlighting the growth potential of pulsed field ablation (PFA) in atrial fibrillation treatment. With projections of PFA sales skyrocketing from $100-200 million in... 
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
Unveiling 13 Analyst Insights On Boston Scientific
Via Benzinga

Performance

YTD
+16.60%
+16.60%
1 Month
+0.30%
+0.30%
3 Month
+11.93%
+11.93%
6 Month
+34.61%
+34.61%
1 Year
+30.34%
+30.34%

More News

Read More
5 Things to Know in Investing This Week
Via Benzinga
Looking Into Boston Scientific's Recent Short Interest
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today
Via Benzinga
NYSE:BSX may be ready to breakout.
Via Chartmill
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today
Via Benzinga
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst
Via Investor's Business Daily
Topics Death
Exposures Death
Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher
Via Investor's Business Daily
17 Analysts Have This To Say About Boston Scientific
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
Via Benzinga
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Boston Scientific Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
The Hot List: 3 AI Stocks Worth Buying on Weakness
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect
Via Benzinga
Citadel Is The Most Successful Hedge Fund In History: Here Are Its Top Investment Picks
Via Benzinga
Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
Key Takeaways From Boston Scientific Analyst Ratings
Via Benzinga
Boston Scientific Corp. (NYSE: BSX) Sets New 52-Week High in Friday Session
Via Investor Brand Network
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
Via Benzinga
Stryker Stock Sees Relative Strength Rating Jump To 84
Via Investor's Business Daily
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.